title: Canaglifozin (Invokana) for type 2 diabetes.
mesh_terms: D000818:Animals; D000068896:Canagliflozin; D002986:Clinical Trials as Topic / Q000379:methods; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D005960:Glucosides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D051297:Sodium-Glucose Transporter 2 / Q000378:metabolism; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D013876:Thiophenes / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D005960:Glucosides; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D013876:Thiophenes; D000068896:Canagliflozin